IRPSX
Price
$11.50
Change
+$0.04 (+0.35%)
Updated
Jul 3 closing price
Net Assets
288.37M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

IRPSX vs VIVAX

Header iconIRPSX vs VIVAX Comparison
Open Charts IRPSX vs VIVAXBanner chart's image
VY® T. Rowe Price Equity Income S
Price$11.50
Change+$0.04 (+0.35%)
VolumeN/A
Net Assets288.37M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
IRPSX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IRPSX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRPSX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. IRPSX (288M). VIVAX pays higher dividends than IRPSX: VIVAX (2.06) vs IRPSX (1.58). IRPSX was incepted earlier than VIVAX: IRPSX (36 years) vs VIVAX (33 years). IRPSX (0.89) is less costly to investors than VIVAX (0.17). IRPSX is a more actively managed with annual turnover of: 21.00 vs. VIVAX (9.00). IRPSX has a lower initial minimum investment than VIVAX: IRPSX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. IRPSX (6.17). VIVAX return over 5 years is better than : 80.14 vs. IRPSX (53.52).
IRPSXVIVAXIRPSX / VIVAX
Total Expense Ratio0.860.17506%
Annual Report Gross Expense Ratio0.890.17524%
Fund Existence36 years33 years-
Gain YTD7.5776.209122%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets288M189B0%
Annual Yield % from dividends1.582.0677%
Returns for 1 year6.1712.0451%
Returns for 3 years9.9035.1628%
Returns for 5 years53.5280.1467%
Returns for 10 years-11.44115.74-10%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.910.03
+1.60%
Emeren Group Ltd
CE60.880.26
+0.43%
Celanese Corp
BNL16.340.03
+0.18%
Broadstone Net Lease
BCLI1.16-0.01
-0.85%
Brainstorm Cell Therapeutics
ECX2.16-0.04
-1.82%
ECARX Holdings